Efforts are continuing to ensure the continued flow of medicines from Great Britain to Northern Ireland from next year, with both the EU and the UK coming up with new proposals to address the supply chain challenges caused by the Northern Ireland Protocol.
Medicine supplies are at risk because the NIP effectively keeps Northern Ireland within the EU single market for goods and therefore subject to EU medicines regulations